Dr Kirsty Limited 09262136 false 2022-04-01 2023-03-31 2023-03-31 The principal activity of the company is beauty and cosmetic services Digita Accounts Production Advanced 6.30.9574.0 true 09262136 2022-04-01 2023-03-31 09262136 2023-03-31 09262136 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-03-31 09262136 core:CurrentFinancialInstruments 2023-03-31 09262136 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 09262136 core:FurnitureFittingsToolsEquipment 2023-03-31 09262136 core:OtherPropertyPlantEquipment 2023-03-31 09262136 bus:SmallEntities 2022-04-01 2023-03-31 09262136 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 09262136 bus:FullAccounts 2022-04-01 2023-03-31 09262136 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 09262136 bus:RegisteredOffice 2022-04-01 2023-03-31 09262136 bus:Director1 2022-04-01 2023-03-31 09262136 bus:OrdinaryShareClass1 bus:CumulativeShares 2022-04-01 2023-03-31 09262136 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 09262136 core:ComputerEquipment 2022-04-01 2023-03-31 09262136 core:FurnitureFittingsToolsEquipment 2022-04-01 2023-03-31 09262136 core:OfficeEquipment 2022-04-01 2023-03-31 09262136 core:OtherPropertyPlantEquipment 2022-04-01 2023-03-31 09262136 core:PlantMachinery 2022-04-01 2023-03-31 09262136 countries:England 2022-04-01 2023-03-31 09262136 2022-03-31 09262136 core:FurnitureFittingsToolsEquipment 2022-03-31 09262136 core:OtherPropertyPlantEquipment 2022-03-31 09262136 2021-04-01 2022-03-31 09262136 2022-03-31 09262136 bus:OrdinaryShareClass1 bus:CumulativeShares 2022-03-31 09262136 core:CurrentFinancialInstruments 2022-03-31 09262136 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 09262136 core:FurnitureFittingsToolsEquipment 2022-03-31 09262136 core:OtherPropertyPlantEquipment 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09262136

Dr Kirsty Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2023

 

Dr Kirsty Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

Dr Kirsty Limited

Company Information

Director

Dr Kirsty-Anne Noble

Registered office

2 Clifton Road
Brighton
BN1 3HP

Accountants

BJP Finance Ltd
Chartered Accountants
34 Market Street
Bradford-On-Avon
Wiltshire
BA15 1LL

 

Dr Kirsty Limited

(Registration number: 09262136)
Balance Sheet as at 31 March 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

-

82

Current assets

 

Stocks

5

-

1,400

Debtors

6

619

73

Cash at bank and in hand

 

1,269

23,322

 

1,888

24,795

Creditors: Amounts falling due within one year

7

(900)

(8,480)

Net current assets

 

988

16,315

Total assets less current liabilities

 

988

16,397

Provisions for liabilities

-

(19)

Net assets

 

988

16,378

Capital and reserves

 

Called up share capital

8

1

1

Retained earnings

987

16,377

Shareholders' funds

 

988

16,378

For the financial year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 2 February 2024
 

.........................................
Dr Kirsty-Anne Noble
Director

 

Dr Kirsty Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
2 Clifton Road
Brighton
BN1 3HP
United Kingdom

These financial statements were authorised for issue by the director on 2 February 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Dr Kirsty Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer Equipment

50% Straight line

Plant & Machinery

33% Straight line

Office Equipment

25% Straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

 

Dr Kirsty Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

 

Dr Kirsty Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 April 2022

1,931

1,084

3,015

At 31 March 2023

1,931

1,084

3,015

Depreciation

At 1 April 2022

1,910

1,023

2,933

Charge for the year

21

61

82

At 31 March 2023

1,931

1,084

3,015

Carrying amount

At 31 March 2023

-

-

-

At 31 March 2022

21

61

82

5

Stocks

2023
£

2022
£

Other inventories

-

1,400

6

Debtors

Current

2023
£

2022
£

Other debtors

619

73

7

Creditors

Creditors: amounts falling due within one year

Note

2023
£

2022
£

Due within one year

 

Loans and borrowings

9

120

18

Taxation and social security

 

-

7,293

Accruals and deferred income

 

780

1,169

 

900

8,480

 

Dr Kirsty Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

8

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary Shares of £1 each

1

1

1

1

         

9

Loans and borrowings

2023
£

2022
£

Current loans and borrowings

Other borrowings

120

18

10

Dividends

   

2023

 

2022

   

£

 

£

Interim dividend of £13,000.00 (2022 - £15,000.00) per ordinary share

 

13,000

 

15,000